Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
158 hedge funds and large institutions have $1.61B invested in Abiomed Inc in 2014 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 42 increasing their positions, 58 reducing their positions, and 11 closing their positions.
1,117% more call options, than puts
Call options by funds: $3.43M | Put options by funds: $282K
227% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 11
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
36% more capital invested
Capital invested by funds: $1.19B → $1.61B (+$428M)
15% more funds holding
Funds holding: 137 → 158 (+21)
28% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$25.6M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$19M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$14.4M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$9.08M |
| 5 |
D.E. Shaw & Co
New York
|
+$8.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$54.4M |
| 2 |
Tiger Global Management
New York
|
-$42M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$36M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$35.8M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$17.1M |
ABMD Hedge Fund Activity: Q4 2014 in Review
158 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2014, worth a combined $1.61B — up 36% from $1.19B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new ABMD positions and 11 closed out — a net gain of 25 holders — while 42 added to existing stakes and 58 trimmed.
The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $25.6M. The largest seller was Jackson Square Partners, cutting an estimated $54.4M.
- 158 institutional investors held Abiomed Inc (ABMD) as of Q4 2014, up from 137 in Q3 2014.
- Funds reported $1.61B of Abiomed Inc stock for Q4 2014, up 36% quarter-over-quarter.
- 36 funds opened new Abiomed Inc positions in Q4 2014 and 11 closed out, a net change of +25 holders.
- The largest Abiomed Inc buyer in Q4 2014 was Lord, Abbett & Co, an estimated $25.6M added.
- The largest Abiomed Inc seller in Q4 2014 was Jackson Square Partners, an estimated $54.4M sold.
Based on aggregated 13F filings for Q4 2014.